Walleye Capital LLC Novartis Ag Transaction History
Walleye Capital LLC
- $24 Billion
- Q3 2025
A detailed history of Walleye Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Walleye Capital LLC holds 199,900 shares of NVS stock, worth $26.3 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
199,900
Previous 36,800
443.21%
Holding current value
$26.3 Million
Previous $4.45 Million
475.68%
% of portfolio
0.11%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,600Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...